Imipenem (+Cilastatin Sodium)
Product Description
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD.
-
Country/Region:China
-
On CPHI since:2015
-
Certificates:4
-
Employees:5000+
Company types
Primary activities
Categories
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD.
-
Country/Region:China
-
On CPHI since:2015
-
Certificates:4
-
Employees:5000+
Company types
Primary activities
More Products from ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (99)
-
Product Finerenone
CN Status(I) -
Product Fluralaner
API for Animal HealthIn house
US(Submitted) -
Product Fluvastatin Sodium
Cardiovascular APIWS+YBH
CN Status(A) -
Product Glucosamine Sulfate Sodium Chloride
YBHCN Status(A) -
Product Glutathione
JP, WS1+YBHCN Status(A) -
Product Imidacloprid
API for Animal HealthEP
CEP, US -
Product Ivermectin
For human use: Anti-infection APIUSP, EP, CVP, IP
USDMF, CEP, JDMF, CN Status(A)
For animal use:
Animal Healthcare
USP, EP, CVP
CEP, US/JP/CN Status -
Product Letermovir
Anti-infection APIIn house
CN Status(A) -
Product Linezolid
Anti-infection APIUSP, YBY
CN Status(A) -
Product Lurasidone HCl
In houseUSDMF(Submitted)
CN Status(A) -
Product Maribavir
Therapeutic Area: CMV
Status: Early
-
Product Mavacamten
Therapeutic Area: Cardiovascular
Status: Early